A new report from technology consultancy Future Processing finds that the gap between a successful AI pilot and a failed production rollout in insurance is not model capability, but whether the business case, data, operating process and governance have been validated before committing to build. The finding matters because the financial upside is already measurable: analytics leaders among large carriers operate with combined ratios around six points below the market, while AI-enabled insurance operations can reduce operating costs by up to 21%.
The pilot-production paradox
McKinsey's 2025 State of AI identified only a small group - around 6% of organisations - that combined significant value from AI with more than 5% EBIT attribution. Despite heavy investment in pilots, most programmes stall at the scaling stage. Future Processing's June 2026 AI Scaling Paradox report argues that the decisive gap is usually not technical. The model may work, but the organisation has not validated the economics, the data pipelines, the integration points or the governance framework needed to run it in production.
Why claims triage exposes the gap
A claims triage pilot can prove a model classifies or prioritises claims on a curated dataset. Production demands a different level of evidence: reliable data lineage, integration with the claims platform, clear exception thresholds, a named decision owner, human review, monitoring and an audit trail that shows how a decision was reached and corrected. For claims professionals, the distinction between what a model can do and what a business can rely on is central to scaling AI for Insurance. A pilot tests whether the model can produce an answer. Production tests whether the insurer can rely on that answer.
Automation depends on the cost of error
The appropriate level of automation shifts with the consequence of error. For high-volume, low-value claims, such as straightforward motor claims below $1,000, straight-through processing can materially reduce settlement time; market leaders report reductions of up to 80%. In specialty claims, where a single loss may run into tens or hundreds of millions, the more credible use of AI is decision support: surfacing relevant information, identifying anomalies and improving reserving or coverage analysis, while keeping accountable human judgement in the process.
The UK data problem
The UK market adds another layer of risk. DSIT's 2025 AI Adoption Research found that 71% of UK firms had not identified a concrete AI use case. Board-level ambition often moves faster than use-case definition. Adam Gaca, Managing Director UK&I and Vice President of Innovation at Future Processing, said: "UK insurers rarely lack AI ideas. What is usually missing is a baseline, a named business owner and a clear definition of what better looks like. If those are absent, a pilot may show that the technology works without proving that the business should deploy it."
Separating two decisions before delivery
The practical lesson is to separate two questions before any build: is the use case economically justified, and is the organisation ready to scale it? This discipline is a core theme in the broader effort to scale AI for Executives & Strategy. A credible assessment must also allow for a no-go outcome. Stopping a weak use case early is not a failure of innovation; it is disciplined investment and risk control.
Why this matters for insurance professionals
The takeaway for insurance leaders is to treat the pilot as a business-case test, not just a technology test. Naming a business owner, defining what better looks like, and accepting a no-go decision before scaling can prevent expensive production failures. A model that works in a sandbox does not automatically mean a business should deploy it. The gap between the two is where most AI value in insurance is lost.
Your membership also unlocks:
